Skip to content

Chinook Therapeutics, Inc.: filings

Every Chinook Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 34 filings, each linked to its SEC index.

Filing record ends 2023-08-07

The latest filing in this captured record is a 10-Q filed 2023-08-07. No later filing is in the SEC companyfacts record captured on 2026-09-22. Chinook Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-08-07fiscal Q2 2023411140000950170-23-039041
10-Q2023-05-09fiscal Q1 202341860000950170-23-019647
10-K2023-02-27fiscal FY 2022441130001564590-23-002589
10-Q2022-11-10fiscal Q3 2022421220001564590-22-037390
10-Q2022-08-08fiscal Q2 2022421180001564590-22-028434
10-Q2022-05-12fiscal Q1 202239820001564590-22-019844
10-K2022-03-17fiscal FY 202144870001564590-22-010862
10-Q2021-11-08fiscal Q3 2021411080001564590-21-055067
10-Q2021-08-12fiscal Q2 2021421100001564590-21-043974
10-Q2021-05-12fiscal Q1 202143860001564590-21-026998
10-K2021-04-07fiscal FY 202046800001564590-21-018017
10-Q2020-11-05fiscal Q3 2020461290001564590-20-051403
10-Q2020-08-03fiscal Q2 2020451230001564590-20-035508
10-Q2020-05-04fiscal Q1 202043910001564590-20-020832
10-K2020-03-09fiscal FY 2019481470001564590-20-009364
10-Q2019-11-07fiscal Q3 2019421190001564590-19-041741
10-Q2019-08-01fiscal Q2 2019421150001564590-19-027956
10-Q2019-05-07fiscal Q1 201942870001564590-19-016502
10-K2019-02-27fiscal FY 2018461470001564590-19-004942
10-Q2018-10-30fiscal Q3 2018411080001564590-18-025616
10-Q2018-08-01fiscal Q2 2018411080001564590-18-018447
10-Q2018-05-02fiscal Q1 201836740001564590-18-010326
10-K2018-03-01fiscal FY 2017411300001564590-18-004135
10-Q2017-10-31fiscal Q3 201736980001564590-17-020526
10-Q2017-08-02fiscal Q2 2017391090001564590-17-014897
10-Q2017-05-02fiscal Q1 201735710001564590-17-008118
10-K2017-03-01fiscal FY 2016411240001564590-17-003099
10-Q2016-11-02fiscal Q3 2016381080001564590-16-026976
10-Q2016-08-03fiscal Q2 2016391110001564590-16-022375
10-Q2016-05-02fiscal Q1 201634700001564590-16-017299
10-K2016-03-08fiscal FY 2015401120001564590-16-014215
10-Q2015-11-23fiscal Q3 201534930001564590-15-011069
10-Q2015-08-11fiscal Q2 201528730001564590-15-006873
10-Q2015-05-28fiscal Q1 201527550001564590-15-004699

Inspect the source

Entity
Chinook Therapeutics, Inc. / CIK 0001435049
Captured
SEC response SHA-256
9aab66fd95fc79b975aa91de3b98ad2a8516b88b5d4906fedf399e70b93a426c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001435049.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))